Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Testing should be based on the phenotype for antithrombin, protein C and protein S; on the phenotype and genotype (factor V Leiden mutation) for activated protein C resistance; and on the genotype (G20210A mutation) for hyperprothrombinemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP830721.RAbi6f2TyL2KmWfgjuUx1DfRLvadnHdxiZUaHdvk_0y0g130_assertion description "[Testing should be based on the phenotype for antithrombin, protein C and protein S; on the phenotype and genotype (factor V Leiden mutation) for activated protein C resistance; and on the genotype (G20210A mutation) for hyperprothrombinemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP830721.RAbi6f2TyL2KmWfgjuUx1DfRLvadnHdxiZUaHdvk_0y0g130_provenance.
• NP296686.RAnlfAO9Y8BW-al3zMmRvXF4EZSQBB3pt25kVzcGcFfhE130_assertion description "[Testing should be based on the phenotype for antithrombin, protein C and protein S; on the phenotype and genotype (factor V Leiden mutation) for activated protein C resistance; and on the genotype (G20210A mutation) for hyperprothrombinemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP296686.RAnlfAO9Y8BW-al3zMmRvXF4EZSQBB3pt25kVzcGcFfhE130_provenance.
• NP413633.RAsfN2x4-rVFPoZtBqCHQayXl_xjYe9gKZ6RwRUfh9rkE130_assertion description "[Testing should be based on the phenotype for antithrombin, protein C and protein S; on the phenotype and genotype (factor V Leiden mutation) for activated protein C resistance; and on the genotype (G20210A mutation) for hyperprothrombinemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP413633.RAsfN2x4-rVFPoZtBqCHQayXl_xjYe9gKZ6RwRUfh9rkE130_provenance.
• NP155311.RALDw54292-lAXCx3FNWNfBI26Px6OnQMYzdaOZ8aqPYc130_assertion description "[Testing should be based on the phenotype for antithrombin, protein C and protein S; on the phenotype and genotype (factor V Leiden mutation) for activated protein C resistance; and on the genotype (G20210A mutation) for hyperprothrombinemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP155311.RALDw54292-lAXCx3FNWNfBI26Px6OnQMYzdaOZ8aqPYc130_provenance.
• NP529473.RAAJJCQU1Walcfrpk-BSH0gou-Jdzv456KVxDHoXUArsI130_assertion description "[Testing should be based on the phenotype for antithrombin, protein C and protein S; on the phenotype and genotype (factor V Leiden mutation) for activated protein C resistance; and on the genotype (G20210A mutation) for hyperprothrombinemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP529473.RAAJJCQU1Walcfrpk-BSH0gou-Jdzv456KVxDHoXUArsI130_provenance.
• NP389912.RAakki-PX17wyAi7Q_VM3KUXFgTzHcgOaQXeRe-ixcE44130_assertion description "[Testing should be based on the phenotype for antithrombin, protein C and protein S; on the phenotype and genotype (factor V Leiden mutation) for activated protein C resistance; and on the genotype (G20210A mutation) for hyperprothrombinemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP389912.RAakki-PX17wyAi7Q_VM3KUXFgTzHcgOaQXeRe-ixcE44130_provenance.
• NP641014.RA3G3qBMqDVC-_r_BBKb5mko1wECrtYXoO4NHqk8YSqmM130_assertion description "[Testing should be based on the phenotype for antithrombin, protein C and protein S; on the phenotype and genotype (factor V Leiden mutation) for activated protein C resistance; and on the genotype (G20210A mutation) for hyperprothrombinemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641014.RA3G3qBMqDVC-_r_BBKb5mko1wECrtYXoO4NHqk8YSqmM130_provenance.
• NP529475.RAzv7Oyg6OoNH3GPXIYR2MjsEknzNEXw_13QvvmzdlLdk130_assertion description "[Testing should be based on the phenotype for antithrombin, protein C and protein S; on the phenotype and genotype (factor V Leiden mutation) for activated protein C resistance; and on the genotype (G20210A mutation) for hyperprothrombinemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP529475.RAzv7Oyg6OoNH3GPXIYR2MjsEknzNEXw_13QvvmzdlLdk130_provenance.
• NP529476.RA-7Sqfb3cuFSWkmNEZi5eJdxrVdFOwZs0NLkvAEnGcQg130_assertion description "[Testing should be based on the phenotype for antithrombin, protein C and protein S; on the phenotype and genotype (factor V Leiden mutation) for activated protein C resistance; and on the genotype (G20210A mutation) for hyperprothrombinemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP529476.RA-7Sqfb3cuFSWkmNEZi5eJdxrVdFOwZs0NLkvAEnGcQg130_provenance.
• NP529478.RAwDm17j81qIBPkysPz87f2BeB-aZYq5QRBCv1k21deA4130_assertion description "[Testing should be based on the phenotype for antithrombin, protein C and protein S; on the phenotype and genotype (factor V Leiden mutation) for activated protein C resistance; and on the genotype (G20210A mutation) for hyperprothrombinemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP529478.RAwDm17j81qIBPkysPz87f2BeB-aZYq5QRBCv1k21deA4130_provenance.
• NP529482.RA-pUowWykfaV7tOMfqY16oHXlgiqg1QytHCK2-VxnGVE130_assertion description "[Testing should be based on the phenotype for antithrombin, protein C and protein S; on the phenotype and genotype (factor V Leiden mutation) for activated protein C resistance; and on the genotype (G20210A mutation) for hyperprothrombinemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP529482.RA-pUowWykfaV7tOMfqY16oHXlgiqg1QytHCK2-VxnGVE130_provenance.
• NP529484.RAwyDTHsjDC3NQJ3sjVKw4R9zKzVuzEu0gUoVHSMv9Fw4130_assertion description "[Testing should be based on the phenotype for antithrombin, protein C and protein S; on the phenotype and genotype (factor V Leiden mutation) for activated protein C resistance; and on the genotype (G20210A mutation) for hyperprothrombinemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP529484.RAwyDTHsjDC3NQJ3sjVKw4R9zKzVuzEu0gUoVHSMv9Fw4130_provenance.
• NP529474.RAbHym8kA6leMOqrc1hfC7OCUDmZFwpCX_SpL9FDvXBC8130_assertion description "[Testing should be based on the phenotype for antithrombin, protein C and protein S; on the phenotype and genotype (factor V Leiden mutation) for activated protein C resistance; and on the genotype (G20210A mutation) for hyperprothrombinemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP529474.RAbHym8kA6leMOqrc1hfC7OCUDmZFwpCX_SpL9FDvXBC8130_provenance.
• NP529481.RARXyzjNcMd0k5-U_x6dx3A1LubiEF-4svPuP72f-qpLY130_assertion description "[Testing should be based on the phenotype for antithrombin, protein C and protein S; on the phenotype and genotype (factor V Leiden mutation) for activated protein C resistance; and on the genotype (G20210A mutation) for hyperprothrombinemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP529481.RARXyzjNcMd0k5-U_x6dx3A1LubiEF-4svPuP72f-qpLY130_provenance.
• NP389903.RAFlWdA22O1bVkbEp1E8OOGEnpDrCBOmRIqwAUNv7LxEY130_assertion description "[Testing should be based on the phenotype for antithrombin, protein C and protein S; on the phenotype and genotype (factor V Leiden mutation) for activated protein C resistance; and on the genotype (G20210A mutation) for hyperprothrombinemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP389903.RAFlWdA22O1bVkbEp1E8OOGEnpDrCBOmRIqwAUNv7LxEY130_provenance.
• NP529483.RAE0YAv8fZDt0TDFVdcvCY549PGhf0fnCFU2k7P7Sz718130_assertion description "[Testing should be based on the phenotype for antithrombin, protein C and protein S; on the phenotype and genotype (factor V Leiden mutation) for activated protein C resistance; and on the genotype (G20210A mutation) for hyperprothrombinemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP529483.RAE0YAv8fZDt0TDFVdcvCY549PGhf0fnCFU2k7P7Sz718130_provenance.
• NP389791.RAl-dorYEe62R8HYJFgv5jEPMYr4K0dIC7PGPakQ5KD-U130_assertion description "[Testing should be based on the phenotype for antithrombin, protein C and protein S; on the phenotype and genotype (factor V Leiden mutation) for activated protein C resistance; and on the genotype (G20210A mutation) for hyperprothrombinemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP389791.RAl-dorYEe62R8HYJFgv5jEPMYr4K0dIC7PGPakQ5KD-U130_provenance.
• NP641641.RApNsRGTfMU1uzBzVjIQcklmx3szQVH_jtak5gYTH4PZo130_assertion description "[Testing should be based on the phenotype for antithrombin, protein C and protein S; on the phenotype and genotype (factor V Leiden mutation) for activated protein C resistance; and on the genotype (G20210A mutation) for hyperprothrombinemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641641.RApNsRGTfMU1uzBzVjIQcklmx3szQVH_jtak5gYTH4PZo130_provenance.
• NP529479.RAmhUlvpVkoRJnrjOOA3Tyk9hcljRjcPghgikEj5BGYTA130_assertion description "[Testing should be based on the phenotype for antithrombin, protein C and protein S; on the phenotype and genotype (factor V Leiden mutation) for activated protein C resistance; and on the genotype (G20210A mutation) for hyperprothrombinemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP529479.RAmhUlvpVkoRJnrjOOA3Tyk9hcljRjcPghgikEj5BGYTA130_provenance.
• NP529480.RApjaW6JuFUkkWYwxIKZa8HPOQJMKljv9ukzP8Qxx3N1w130_assertion description "[Testing should be based on the phenotype for antithrombin, protein C and protein S; on the phenotype and genotype (factor V Leiden mutation) for activated protein C resistance; and on the genotype (G20210A mutation) for hyperprothrombinemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP529480.RApjaW6JuFUkkWYwxIKZa8HPOQJMKljv9ukzP8Qxx3N1w130_provenance.
• NP529485.RAtueU9iPQ7MY9ftb5x4QyQeCIE_-5Sjv7NhAel-__-vg130_assertion description "[Testing should be based on the phenotype for antithrombin, protein C and protein S; on the phenotype and genotype (factor V Leiden mutation) for activated protein C resistance; and on the genotype (G20210A mutation) for hyperprothrombinemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP529485.RAtueU9iPQ7MY9ftb5x4QyQeCIE_-5Sjv7NhAel-__-vg130_provenance.